CLINICAL SIGNIFICANCE OF CD33 NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH GEMTUZUMAB-OZOGAMICIN-CONTAINING CHEMOTHERAPY

PURPOSE: Purpose of this study was to evaluate clinical implications of CD33 SNPs in pediatric acute myeloid leukemia (AML) patients treated with gemtuzumab ozogamicin (GO) based therapy. EXPERIMENTAL DESIGN: We genotyped four CD33 SNPs: rs35112940 (G>A; Arg304Gly), rs12459419 (C>T; Ala14Val),...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mortland, Leslie, Alonzo, Todd A, Walter, Roland B, Gerbing, Robert B, Mitra, AK, Pollard, Jessica A, Loken, Michael R, Hirsch, Betsy, Raimondi, Susana, Franklin, Janet, Pounds, Stanley, Cao, Xueyuan, Rubnitz, Jeffrey E, Ribeiro, Raul C, Gamis, Alan, Meshinchi, Soheil, Lamba, Jatinder K
التنسيق: Artigo
اللغة:Inglês
منشور في: 2013
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602123/
https://ncbi.nlm.nih.gov/pubmed/23444229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3115
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة